It has anti-tumor proliferation effect, has obvious immunomodulatory effect in vitro, and can inhibit viral replication. By binding to specific membrane receptors on the cell surface, it initiates a series of intracellular processes, including the induction of certain enzymes, thereby inhibiting viral replication in virus-infected cells, inhibiting cell proliferation, and a series of immunomodulatory effects, such as enhancing the function of macrophages and lymphocytes on target cells.

Pharmacological effects: The results of preclinical cell culture systems and animal xenogeneic tumor transplantation experiments showed that recombinant human interferon α2b has anti-tumor proliferation effects and has obvious immunomodulatory effects in vitro. In vitro studies have also shown that recombinant human interferon α2b can inhibit viral replication. Interferon produces the above effects by binding to specific membrane receptors on the cell surface. Many studies have suggested that once interferon binds to cell receptors, it can initiate a series of complex intracellular processes, including the induction of certain enzymes. It is believed that this process, at least to some extent, leads to various cellular responses of interferon, including inhibition of viral replication in virus-infected cells, inhibition of cell proliferation, and a series of immunomodulatory effects, such as enhancing the action of macrophages and lymphocytes on target cells.

Pharmacological effects: The results of preclinical cell culture systems and animal xenogeneic tumor transplantation experiments showed that recombinant human interferon α2b has anti-tumor proliferation effects and has obvious immunomodulatory effects in vitro. In vitro studies have also shown that recombinant human interferon α2b can inhibit viral replication. Interferon produces the above effects by binding to specific membrane receptors on the cell surface. Many studies have suggested that once interferon binds to cell receptors, it can initiate a series of complex intracellular processes, including the induction of certain enzymes. It is believed that this process, at least to some extent, leads to various cellular responses of interferon, including inhibition of viral replication in virus-infected cells, inhibition of cell proliferation, and a series of immunomodulatory effects, such as enhancing the action of macrophages and lymphocytes on target cells.

It has anti-tumor proliferation effect, has obvious immunomodulatory effect in vitro, and can inhibit viral replication. By binding to specific membrane receptors on the cell surface, it initiates a series of intracellular processes, including the induction of certain enzymes, thereby inhibiting viral replication in virus-infected cells, inhibiting cell proliferation, and a series of immunomodulatory effects, such as enhancing the effect of macrophages and lymphocytes on target cells.

Pharmacological effects: The results of preclinical cell culture systems and animal xenogeneic tumor transplantation experiments showed that recombinant human interferon α2b has anti-tumor proliferation effects and has obvious immunomodulatory effects in vitro. In vitro studies have also shown that recombinant human interferon α2b can inhibit viral replication. Interferon produces the above effects by binding to specific membrane receptors on the cell surface. Many studies have suggested that once interferon binds to cell receptors, it can initiate a series of complex intracellular processes, including the induction of certain enzymes. It is believed that this process, at least to some extent, leads to various cellular responses of interferon, including inhibition of viral replication in virus-infected cells, inhibition of cell proliferation, and a series of immunomodulatory effects, such as enhancing the action of macrophages and lymphocytes on target cells.

Pharmacological effects: The results of preclinical cell culture systems and animal xenogeneic tumor transplantation experiments showed that recombinant human interferon α2b has anti-tumor proliferation effects and has obvious immunomodulatory effects in vitro. In vitro studies have also shown that recombinant human interferon α2b can inhibit viral replication. Interferon produces the above effects by binding to specific membrane receptors on the cell surface. Many studies have suggested that once interferon binds to cell receptors, it can initiate a series of complex intracellular processes, including the induction of certain enzymes. It is believed that this process, at least to some extent, leads to various cellular responses of interferon, including inhibition of viral replication in virus-infected cells, inhibition of cell proliferation, and a series of immunomodulatory effects, such as enhancing the action of macrophages and lymphocytes on target cells.

It has broad-spectrum antiviral, anti-tumor, cell proliferation inhibition and immune function enhancement effects. Interferon binds to cell surface receptors, induces cells to produce a variety of antiviral proteins, inhibits virus reproduction in cells, and improves immune function, including enhancing the phagocytic function of macrophages, enhancing the cytotoxicity of lymphocytes to target cells and the function of natural killer cells.

Pharmacology: Recombinant human interferon alpha 2b has broad-spectrum antiviral, anti-tumor, cell proliferation inhibition and immune function enhancement effects. Interferon binds to cell surface receptors, induces cells to produce a variety of antiviral proteins, inhibits virus reproduction in cells, and improves immune function, including enhancing the phagocytic function of macrophages, enhancing the cytotoxicity of lymphocytes to target cells and the function of natural killer cells. Toxicology: Acute toxicity test: The product was injected intraperitoneally and intravenously into mice, with the dosage of 1.5 times 109 IU/kg and 1.5 times 108 IU/kg, respectively, which is 105 and 104 times the therapeutic dose for humans. No acute poisoning symptoms occurred, and no animals died.

Broad-spectrum antiviral, anti-tumor, inhibiting cell proliferation and improving immune function. Interferon binds to cell surface receptors, induces cells to produce a variety of antiviral proteins, inhibits virus reproduction in cells, and improves immune function, including enhancing the phagocytic function of macrophages, enhancing the cytotoxicity of lymphocytes to target cells and the function of natural killer cells.

Pharmacology: Recombinant human interferon alpha 2b has broad-spectrum antiviral, anti-tumor, cell proliferation inhibition and immune function enhancement effects. Interferon binds to cell surface receptors, induces cells to produce a variety of antiviral proteins, inhibits virus reproduction in cells, and improves immune function, including enhancing the phagocytic function of macrophages, enhancing the cytotoxicity of lymphocytes to target cells and the function of natural killer cells. Toxicology: Acute toxicity test: The product was injected intraperitoneally and intravenously into mice, with the dosage of 1.5 times 109 IU/kg and 1.5 times 108 IU/kg, respectively, which is 105 and 104 times the therapeutic dose for humans. No acute poisoning symptoms occurred, and no animals died.